Search research articles
Contact Us
Filters
Showing results (61-70 of 117) with videos related to
Page
of 12
Sort By:
Journal of Cell Science
|
July 28, 2021
DNA binding alters ARv7 dimer interactions
Fatma Özgün, Zeynep Kaya, Tunç Morova, et al.
Nature Communications
|
February 13, 2020
Androgen receptor-binding sites are highly mutated in prostate cancer
Tunç Morova, Daniel R McNeill, Nada Lallous, et al.
The Prostate
|
October 21, 2021
Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations
Ceren Şeref, Ömer Acar, Mert Kılıç, et al.
Oncogene
|
December 12, 2019
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
Hilal Saraç, Tunç Morova, Elisabete Pires, et al.
Genome Research
|
June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contexts
Yanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
Clinical Pharmacology and Therapeutics
|
May 19, 2005
A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100
N A Lack, B Green, D C Dale, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
January 10, 2016
Cytotoxicity and mitogenicity assays with real-time and label-free monitoring of human granulosa cells with an impedance-based signal processing technology intergrating micro-electronics and cell biology
Ozgur Oktem, Gamze Bildik, Filiz Senbabaoglu, et al.
BMC Medical Genetics
|
April 27, 2013
Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population
Dawn Me Bowdish, Kaori Sakamoto, Nathan A Lack, et al.
Archiv Der Pharmazie
|
October 10, 2023
5-Fluoro/(trifluoromethoxy)-2-indolinone derivatives with anti-interleukin-1 activity
Özge Soylu-Eter, Zekiye Şeyma Sevinçli, Betül Ersoy, et al.
Journal of Medicinal Chemistry
|
August 18, 2011
Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening
Peter Axerio-Cilies, Nathan A Lack, M Ravi Shashi Nayana, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 117) with videos related to
Sort By:
Page
of 12
Journal of Cell Science
|
July 28, 2021
DNA binding alters ARv7 dimer interactions
Fatma Özgün, Zeynep Kaya, Tunç Morova, et al.
Nature Communications
|
February 13, 2020
Androgen receptor-binding sites are highly mutated in prostate cancer
Tunç Morova, Daniel R McNeill, Nada Lallous, et al.
The Prostate
|
October 21, 2021
Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations
Ceren Şeref, Ömer Acar, Mert Kılıç, et al.
Oncogene
|
December 12, 2019
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
Hilal Saraç, Tunç Morova, Elisabete Pires, et al.
Genome Research
|
June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contexts
Yanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
Clinical Pharmacology and Therapeutics
|
May 19, 2005
A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100
N A Lack, B Green, D C Dale, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
January 10, 2016
Cytotoxicity and mitogenicity assays with real-time and label-free monitoring of human granulosa cells with an impedance-based signal processing technology intergrating micro-electronics and cell biology
Ozgur Oktem, Gamze Bildik, Filiz Senbabaoglu, et al.
BMC Medical Genetics
|
April 27, 2013
Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population
Dawn Me Bowdish, Kaori Sakamoto, Nathan A Lack, et al.
Archiv Der Pharmazie
|
October 10, 2023
5-Fluoro/(trifluoromethoxy)-2-indolinone derivatives with anti-interleukin-1 activity
Özge Soylu-Eter, Zekiye Şeyma Sevinçli, Betül Ersoy, et al.
Journal of Medicinal Chemistry
|
August 18, 2011
Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening
Peter Axerio-Cilies, Nathan A Lack, M Ravi Shashi Nayana, et al.
Page
of 12